Douglas E. Williams
Executive VP R&D and CSO, ZYMOGENETICS INC.
Companies
- Camp4 Therapeutics CorpBoard member Mar 19, 2025 to now1
- Climb Bio, Inc.Board member Nov 12, 2024 to now2
- Sana BiotechnologyEVP & President, R&D Apr 11, 2023 to Mar 8, 20243
- Codiak BioSciences, Inc.Board member Oct 13, 2020 to Mar 30, 20234
- Codiak BioSciences, Inc.Chief executive officer Oct 13, 2020 to Mar 30, 20234
- Codiak BioSciences, Inc.President Oct 13, 2020 to Mar 30, 20234
- Codiak BioSciences, Inc.Officer Jan 23, 2023 to Jan 23, 20235
- Ovid Therapeutics Inc.Board member May 4, 2017 to May 18, 20216
- Panacea Acquisition Corp. IIBoard member Apr 6, 2021 to Apr 6, 20217
- Ironwood PharmaceuticalsBoard member Jun 4, 2014 to Apr 3, 20198
- Regulus Therapeutics Inc.Board member Nov 8, 2012 to Jun 3, 20169
- BiogenEVP Research & Development Jan 19, 2011 to Jun 22, 201510
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Camp4 Therapeutics Corp CAMP2,501 shares11$8.0K at $3.18Apr 11, 2025
- Codiak BioSciences, Inc.7,655 shares12Mar 28, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 28, 2023Sold 41,667 shares at $0.18 of Codiak BioSciences, Inc.12
- Feb 17, 2023Sold 7,681 shares at $0.59 of Codiak BioSciences, Inc.13
- Feb 16, 2023Exercised options 22,969 shares of Codiak BioSciences, Inc.13
- Jan 20, 2023Sold 5,075 shares at $0.58 of Codiak BioSciences, Inc.14
- Jan 19, 2023Exercised options 13,667 shares of Codiak BioSciences, Inc.14
- Aug 17, 2022Sold 7,112 shares at $2.21 of Codiak BioSciences, Inc.13
- Aug 16, 2022Exercised options 22,969 shares of Codiak BioSciences, Inc.13
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARClimb Bio, Inc., Board member
- 3
- 4
- 5SEC EDGARCodiak BioSciences, Inc., Officer
- 6SEC EDGAROvid Therapeutics Inc., Board member
- 7
- 8
- 9
- 10SEC EDGARBiogen, EVP Research & Development
- 11
- 12
- 13SEC EDGARForm 4 filed Feb 21, 2023
- 14SEC EDGARForm 4 filed Jan 23, 2023